NDC 57894-450

TECVAYLI

Teclistamab

TECVAYLI is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is Teclistamab.

• Product ID: 57894-450_a84eedd6-8108-11eb-b7ff-e2fefb2ca371
• NDC: 57894-450
• Product Type: Human Prescription Drug
• Proprietary Name: TECVAYLI
• Generic Name: Teclistamab
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2022-10-25
• Marketing Category: BLA /
• Application Number: BLA761291
• Labeler Name: Janssen Biotech, Inc.
• Substance Name: TECLISTAMAB
• Active Ingredient Strength: 90 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 57894-450-01

1 VIAL, SINGLE-DOSE in 1 CARTON (57894-450-01) > 1.7 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2022-10-25
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "TECVAYLI" or generic name "Teclistamab"

NDC	Brand Name	Generic Name
57894-449	TECVAYLI	teclistamab
57894-450	TECVAYLI	teclistamab